Anika Therapeutics Inc (NASDAQ:ANIK) - Share price - Overview

Stock Report

Anika Therapeutics Inc ANIK

Last Price
$49.68

Day Change
0.70|1.43%

As of 27/06/2017
16:59:54 EDT | USD
Minimum 15 Minutes Delay.

Last Close48.98
Day Range48.69 - 49.99
Mkt Cap728.00Mil
52-Wk Range41.38 - 54.96
Yield %-
ISINUS0352551081
Volume124,064
P/E24.00
P/S7.16
P/CF23.95

Share Price

Financials
201420152016
More ...
Income Statement
Revenue105.5993.00103.38
Operating Income61.4548.1350.61
Net Income38.3230.7632.55
Basic EPS2.612.062.22
Avg. Diluted Shares Outstanding151515
Balance Sheet
Current Assets139.03176.43170.44
Non Current Assets54.9759.3269.81
Total Assets194.00235.75240.25
Current Liabilities5.9717.288.80
Total Liabilities15.9024.9017.47
Total Equity178.10210.85222.77
Cash Flow
Operating Cash Flow39.9839.0623.80
Capital Expenditure-1.55-9.23-14.01
Free Cash Flow38.4329.849.79

In millions, except "Basic EPS". Currency is USD.

Company Profile

Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

122
Key Stats
More ...
Price/Earning TTM22.89
Price/Book3.12
Price/Sales TTM7.06
Rev Growth (3 year avg)11.25
EPS Growth (3 year avg)-
Operating Margin % TTM48.95
Net Margin % TTM31.48
ROE TTM15.01
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.